Delivery Order SPE2DB22D3501-SPE2DB24FUK44
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,444.73 firm fixed-price delivery order is for the supply of Tacrolimus 0.1% ointment, a medication used to treat various skin conditions. The contract has a completion date of January 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Tacrolimus 0.1% ointment. The contract has a potential value of $1,600.00 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not include any set-aside designations. In addition to this specific delivery order, Amerisourcebergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,078.16 firm fixed-price contract is for the supply of TACROLIMUS 0.03% OINTMENT 60GM, with a period of performance through May 9, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP1HY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment, 60 GM, with a ceiling value of $2,807.53. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 9, 2025. The contract is not set aside for any specific type...
- This federal contract award, valued at $2,745.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment 30GM, a prescription medication, to support federal government healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,690.81 with a Firm Fixed Price pricing type. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Tacrolimus 0.1% Ointment 60GM, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 0.03% Ointment, a specialty medication, with a firm fixed price ceiling value of $1,204.63 and a performance period through April 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $6,672.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Tacrolimus 0.1% Ointment, a pharmaceutical product used for medical treatment. This is a firm fixed-price delivery order contract with a completion date of January 11, 2024. The contract was awarded on January 10, 2024 and does not have a set-aside designation, indicating open competition....
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide TACROLIMUS 0.1% OINTMENT 60GM to the Defense Logistics Agency (DLA). The award, valued at $1,367.88, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of June 11, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,140.80, is a Firm Fixed Price Delivery Order to provide 4566861896 - TACROLIMUS 0.1% OINTMENT 60GM. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen Drug Corp is the prime contractor and has no major subcontractors listed. The contract is not designated as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUK44Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,735.86 firm fixed-price contract is for the delivery of Tacrolimus 0.1% Ointment 30 GM, a specialty pharmaceutical product. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set aside for any specific business category. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/31/24 |